Staphylococcal Infections
Information
- Disease name
- Staphylococcal Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT02492958 | Completed | Phase 2 | SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults | June 2015 | September 2016 |
NCT00066989 | Completed | Phase 2 | Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates | July 2003 | August 2004 |
NCT00071214 | Completed | Phase 3 | Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis | September 2003 | September 2005 |
NCT00108160 | Completed | Phase 4 | Preventing Staphylococcal (Staph) Infection | April 2005 | August 2012 |
NCT00113191 | Completed | N/A | Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants | May 2004 | June 2006 |
NCT01447407 | Completed | Phase 1 | Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine | September 2011 | December 2012 |
NCT01643941 | Completed | Phase 1 | Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years | August 2012 | March 2014 |
NCT02364596 | Completed | Phase 1 | Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years | January 2015 | February 2015 |
NCT00063089 | Completed | Phase 1/Phase 2 | Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever | September 2002 | September 2004 |
NCT02502474 | Completed | N/A | Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscopic Screening for Digestive Cancer in the University Hospital of Saint-Etienne | February 2, 2015 | October 20, 2017 |
NCT02557568 | Completed | N/A | Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne | October 2011 | February 2013 |
NCT02595112 | Completed | N/A | Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery | February 4, 2016 | September 5, 2017 |
NCT02640937 | Completed | Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections | November 2011 | November 2015 | |
NCT02782078 | Completed | N/A | Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections | March 6, 2017 | January 3, 2019 |
NCT02971657 | Completed | Bacterial Phenotype of Staphylococcus Aureus Has no Effect on Patients' Clinical Outcome in Orthopedic Device Related Bone Infections | November 2011 | March 2015 | |
NCT03915470 | Completed | Phase 2 | Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection | August 29, 2019 | March 29, 2021 |
NCT04409392 | Completed | Staphylococcus Lugdunensis Prosthetic Joint Infection | February 1, 2021 | April 1, 2021 | |
NCT00156377 | Completed | Phase 4 | Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections | November 2002 | |
NCT00175370 | Completed | N/A | Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus | September 2000 | December 2007 |
NCT00211900 | Completed | Phase 3 | Evaluation of Manufacturing Lot of StaphVAX | March 2005 | November 2005 |
NCT00211913 | Completed | Phase 3 | StaphVAX in Cardiovascular Surgery Patients | June 2004 | January 2006 |
NCT00211926 | Completed | Phase 3 | StaphVAX Immunogenicity in Orthopedic Implant Patients | December 2004 | October 2006 |
NCT00211965 | Completed | Phase 3 | StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery | April 2005 | August 2006 |
NCT00211991 | Completed | Phase 3 | Evaluation of Consistency of StaphVAX Manufacturing Lots | April 2005 | July 2005 |
NCT00217841 | Completed | Phase 3 | Aurograb and Vancomycin in MRSA Infection | January 2004 | March 2006 |
NCT00303069 | Completed | Phase 1 | V710 First-In-Man (FIM) Study (V710-001) | November 2005 | July 2006 |
NCT00419991 | Completed | Phase 4 | Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection | January 2007 | May 2008 |
NCT00427076 | Completed | Phase 3 | Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections | June 2007 | June 2014 |
NCT00501150 | Completed | N/A | Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections | September 2005 | June 2007 |
NCT00620984 | Completed | Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis | August 2006 | December 2009 | |
NCT00631566 | Completed | N/A | Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons | May 2007 | October 2017 |
NCT00666276 | Completed | Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan) | February 2007 | April 2011 | |
NCT00736554 | Completed | What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center? | July 2008 | November 2008 | |
NCT00779246 | Completed | N/A | Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections | June 2008 | July 2009 |
NCT00859677 | Completed | Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection | March 2009 | August 26, 2016 | |
NCT01018641 | Completed | Phase 1 | An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults | January 2010 | July 2011 |
NCT01273922 | Completed | Phase 1 | Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida | January 2011 | December 2011 |
NCT01324440 | Completed | Phase 1 | Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002) | September 2006 | October 2007 |
NCT01364571 | Completed | Phase 1 | Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years | August 2011 | January 2013 |
NCT01431326 | Completed | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | November 2011 | November 2019 | |
NCT05899140 | Not yet recruiting | Phase 4 | Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial | February 1, 2024 | July 31, 2024 |
NCT02664740 | Not yet recruiting | Phase 1/Phase 2 | Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus | June 1, 2022 | August 2024 |
NCT00130260 | Terminated | Phase 3 | Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease | August 2005 | April 2006 |
NCT01196169 | Terminated | Phase 4 | Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty | October 2010 | March 2014 |
NCT04141787 | Unknown status | Phase 4 | Ceftriaxone as Home IV for Staph Infections | July 11, 2019 | March 30, 2024 |
NCT00518076 | Unknown status | Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant | September 2006 | ||
NCT03456544 | Unknown status | Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China | October 31, 2018 | December 31, 2019 | |
NCT01144000 | Unknown status | Phase 2 | Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection | June 2012 | June 2016 |
NCT00646919 | Unknown status | Preoperative Nasal Swabs From Pediatric Patients | |||
NCT00423982 | Unknown status | Phase 4 | Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty | April 2006 | December 2014 |
NCT00368498 | Unknown status | Phase 4 | A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely | June 2006 | December 2007 |
NCT00509847 | Withdrawn | Phase 1/Phase 2 | A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis | February 2009 | October 2009 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D013203